Detailed Analysis of Corporate Apportionment Rules and the Delaware Research & Development Tax Credit

Executive Summary: Defining Corporate Apportionment and the Delaware Advantage

Corporate Apportionment Rules define the fraction of a multi-state corporation’s total taxable income that is subject to a specific state’s income tax rate, ensuring income is allocated fairly across jurisdictions where business activities occur.1

In Delaware, this calculation utilizes a Single Sales Factor (SSF) formula, which heavily favors companies with in-state property and payroll but high out-of-state sales, while also serving as a critical component in calculating the highly valuable, fully refundable Research and Development (R&D) tax credit.2

Delaware’s corporate tax strategy is meticulously structured to attract and retain R&D-intensive businesses. The adoption of the Single Sales Factor (SSF) for general corporate income taxation minimizes the tax burden on entities with significant physical presence in the state, while the R&D tax credit provides a potent incentive, notably due to its full refundability and the elimination of the statewide cap.3 For multi-state corporations, proficiency in interpreting the state’s apportionment methodologies—both for the general income tax and the specialized credit calculations—is essential for accurate tax compliance and maximizing strategic cash flow.

I. The Foundation: Delaware’s Corporate Income Tax Apportionment Regime

Delaware imposes a corporate income tax (CIT) at a rate of 8.7% on the portion of a corporation’s federal taxable income that is allocated and apportioned to the state.5 Every domestic or foreign corporation doing business in Delaware, unless specifically exempt, is required to file a return (Form CIT-TAX).5 A critical procedural note is that Delaware does not permit consolidated corporate income tax returns, requiring each subsidiary or entity to file separately.5

A. Statutory Basis and the Corporate Income Tax Rate

Apportionment is the mechanism by which multi-state business income (or “apportionable income”) is legally divided among the various states where the corporation operates.1 The resultant apportionment percentage determines the fraction of a corporation’s total income subject to the 8.7% rate.5

B. The Evolution to Single Sales Factor (SSF)

Prior to 2017, Delaware utilized an equally weighted three-factor method, giving equal weight (33.3% each) to property, wages, and sales ratios.5 However, the state transitioned its methodology, driven by the “Delaware Competes Act,” to embrace a market-based sourcing approach culminating in the Single Sales Factor (SSF).7

The implementation was phased in progressively to minimize disruption and provide corporate predictability 6:

Table 1: Evolution of Delaware Corporate Apportionment Factors (2016 – Beyond)

Source References: 6

As of January 1, 2020, the apportionment calculation for Delaware relies entirely on the ratio of sales or gross receipts sourced to Delaware versus total sales everywhere.5

C. Strategic Implication: SSF and Incentivizing R&D Facilities

The adoption of the SSF provides a strong economic incentive for corporations that generate significant revenue outside of Delaware but maintain extensive physical operations within the state.2 Since the property and payroll factors carry zero weight in the current apportionment formula, companies are not penalized with higher corporate income tax exposure for establishing substantial physical assets—such as major R&D facilities, laboratories, or manufacturing plants—or for employing large local workforces.2

This mechanism creates a favorable environment for R&D-intensive firms. The strategic effect is that businesses with high in-state payroll and property factors, but low in-state sales, can significantly reduce their overall Delaware corporate income tax liability.2 This regulatory clarity and potential tax minimization strongly encourages companies to locate high-value, job-creating operational hubs, like research centers, in the state, knowing that their state income tax burden will be largely dictated by where their sales are sourced, rather than where their costs are incurred.

II. Deep Dive into the Delaware R&D Tax Credit

The Delaware Research and Development Tax Credit (Del. Code Ann. tit. 30, §§ 2070-2075) is designed to incentivize qualified research expenses (QREs) conducted within the state.8

A. Key Statutory Features: Refundability and Cap Elimination

The state’s R&D credit distinguishes itself from many other state programs through two critical features implemented after January 1, 2017:

1. Full Refundability: The credit is fully refundable.4 If the credit approved by the Division of Revenue exceeds the company’s corporate income tax liability for the tax year, the surplus amount is paid directly to the taxpayer as a cash refund.3 This feature is transformative for early-stage companies and startups that may be incurring substantial QREs but have yet to generate taxable profit, turning a tax asset into immediate cash flow.8
2. Elimination of the Cap: Legislation removed the previous statewide annual cap of $5 million on the total amount of R&D credits issued.4 This guarantees that companies—especially large, innovation-focused corporations—will receive 100 percent of their calculated credit value, eliminating the fiscal uncertainty that arose when credits were subject to a pro-rata reduction if applications exceeded the cap.12

The guaranteed delivery of the full incentive provides large corporations with the necessary financial certainty to commit to major long-term R&D infrastructure investments within Delaware.3

B. Eligibility, Sourcing, and Small Business Status

To be eligible, R&D activities must align with the federal guidelines for QREs outlined in IRC Section 41.4 For state credit purposes, the research activity must be demonstrably conducted within Delaware.8 Delaware Code grants the Director of the Division of Revenue the authority to establish standards for determining QREs and may consider the location where services are physically performed.13

The credit structure includes enhanced benefits for smaller enterprises:

• Small Business Definition: A taxpayer with average annual gross receipts (as defined by IRC § 41(c)(1)(B)) not exceeding the threshold of $20,000,000 qualifies as a small business for the purposes of the credit.4 These businesses benefit from higher credit percentages (20% for Method A and 100% for Method B).4

C. Legislative Decoupling and R&D Expensing

Delaware has taken legislative steps, such as passing HB 255, to manage the impact of federal tax law changes, specifically those affecting the treatment of R&D expenses under IRC Section 174.15 By decoupling from the federal requirement to amortize R&D expenses over several years (post-2021), Delaware effectively allows companies to continue immediately deducting domestic R&D costs for state income tax calculation purposes.16

This creates a scenario where multi-state corporations must maintain two separate R&D expense treatments: one for federal tax computation (amortization) and one for Delaware’s corporate income tax base calculation (immediate deduction). This dual basis tracking, while increasing administrative complexity, ensures that businesses receive the maximum combined state benefit: immediate deduction of the expense plus the fully refundable tax credit derived from the activity.16

III. Apportionment Rules Applied to R&D Credit Calculation (The Critical Nexus)

The term “apportionment” has a dual application in Delaware corporate taxation. While the SSF determines the taxable income base, different apportionment rules apply when calculating the R&D credit itself on Form 2070AC, depending on the chosen methodology.

A. The Annual Election and Calculation Methods

The taxpayer must make an annual, binding election between two credit calculation paths, and this choice is independent of the methodology used for the federal credit.11

Table 2: Delaware R&D Tax Credit Calculation Methods and Rates

Source References: 4

B. Calculation Method A: Excess QREs over the Delaware Base Amount

Method A (the traditional approach) calculates the credit based on current Delaware QREs exceeding a historical Delaware Base Amount. This method relies heavily on accurately apportioned gross receipts from preceding tax years.12

1. Determining the Delaware Fixed-Base Percentage (FBP): The FBP is the ratio of total Delaware QREs to total Delaware gross receipts for the four preceding taxable years.8
2. Calculating the Delaware Base Amount: The Base Amount is calculated by multiplying the FBP by the average annual Delaware gross receipts for the four preceding years.12 A minimum base requirement ensures the base is at least 50% of the current year’s Delaware QREs.8

The key complexity lies in sourcing the historical “Delaware Gross Receipts.” The Division of Revenue guidance dictates that these gross receipts must adhere to the Delaware apportionment rules in effect during those prior years.8 This requires multi-state companies to access and apply the phase-in apportionment factors (the blended three-factor formulas) for years spanning 2017 through 2019, rather than simply applying the current SSF methodology or relying only on sales physically delivered to Delaware.6 Proper documentation and application of these varying historical apportionment rules are paramount for accurate Method A calculation.

C. Calculation Method B: Apportioned Federal Alternative Simplified Credit (ASC)

Method B offers a simpler calculation path that links the state credit directly to the federal credit calculation, using a clear activity-based apportionment factor.

1. The QRE Ratio Apportionment Factor: The mechanism isolates the state benefit based on the physical location of the research activity. The state’s apportioned share of the federal Alternative Simplified Credit (ASC) is determined by multiplying the federal ASC amount by the ratio of Delaware QREs to the taxpayer’s total QREs (federal QREs).11
   $$\text{QRE Ratio} = \frac{\text{Delaware Qualified R\&D Expenses (QREs)}}{\text{Total Qualified R\&D Expenses (QREs)}}$$
   14
2. Calculating the Delaware Credit: The resulting apportioned federal ASC is then multiplied by the applicable rate (50% for standard businesses, 100% for small businesses).12

Method B is generally favored by newer companies or those with high growth, as it avoids the reliance on complex historical gross receipts data and the necessity of tracking varying historical corporate income tax apportionment formulas used prior to the 2020 SSF transition.8 The calculation focuses exclusively on the current-year location of the R&D activity, providing greater stability and predictability.

IV. Delaware Division of Revenue Compliance and Filing Procedures

A. Mandatory Application and Timeline

To claim the credit, taxpayers must submit Form 2070AC (Application and Computation Schedule for Claiming Delaware Research and Development Tax Credits) to the Division of Revenue.12 Prior approval from the DOR is necessary before the credit can be utilized on the income tax return.11

The filing deadline is critical: the application must be submitted on or before September 15th following the close of the taxable year during which the QREs were incurred.4 A required attachment is a copy of the federal research credit Form 6765. Corporations that file a consolidated federal return must attach a pro forma Form 6765 for the separate corporate applicant, as Delaware does not permit consolidated returns.11

B. Utilizing the Approved Credit

Once approved, the credit amount is transferred to Delaware Form 700, the Delaware Income Tax Credit Schedule.12

For pass-through entities, such as S Corporations and Partnerships, the credit is typically calculated at the entity level but allocated to the shareholders or partners based on their respective ownership percentages, allowing the individual owners to claim the benefit.8 The final, most significant benefit is cash recovery: if the approved credit exceeds the corporate or individual tax liability, the State issues a cash refund for the difference.3

V. Multi-State Case Study and Numerical Example

To highlight the importance of the annual election and the impact of the different apportionment methods, consider the following example of a multi-state corporation.

Hypothetical Scenario: BioTech DE-Global Corp. (BDGC)

BDGC is a C Corporation that operates globally but conducts 80% of its research activities in its Delaware facility. The company exceeds the $20 million small business threshold and is subject to standard credit rates.

1. Calculation Method A: Excess QREs

Method A determines the credit based on current QREs exceeding the historical base.

2. Calculation Method B: Apportioned Federal ASC

Method B applies a QRE location ratio to the federally calculated credit.

3. Comparative Outcome

In this situation, BDGC should elect Method B, yielding a credit of $\mathbf{\$ 160,000}$. Method A resulted in a significantly smaller credit because the company’s high historical QREs relative to its historical sales base resulted in a high base amount, minimizing the calculated excess QREs. Method B, however, directly rewards the large current-year R&D concentration in Delaware (80%) by applying that ratio to the generous federal credit amount.

VII. Conclusion and Strategic Implications for Corporations

Delaware’s corporate tax regime presents a nuanced but highly rewarding structure for multi-state corporations focused on innovation. The state’s policy objectives are realized through its distinct use of apportionment rules: the Single Sales Factor (SSF) minimizes the corporate income tax base, while the specialized R&D credit apportionment rules maximize cash generation.

Corporations must employ sophisticated modeling techniques to fully exploit these advantages. The annual requirement to choose between Method A and Method B for the R&D credit (Form 2070AC) necessitates calculating both scenarios, often requiring extensive historical data analysis (for Method A) alongside current activity analysis (for Method B).

For most R&D-intensive companies that have relocated or significantly expanded operations in Delaware, Method B often proves to be the superior choice, as it uses an activity-based QRE ratio to decouple the credit from complex, historically fluctuating corporate income tax apportionment figures. This strategic flexibility, coupled with the credit’s full refundability and guaranteed issuance (due to the elimination of the cap), firmly establishes the Delaware R&D tax credit as one of the most powerful and valuable state incentives available to innovative businesses.

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/